4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001209191-22-039905
Director acquired 20,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP Director | 2022-06-29 | Grant or award | +10,000 | 108,980 | I: show line 1 in the form | ||
| BAKER BROS. ADVISORS LP Director | 2022-06-29 | Grant or award | +10,000 | 2,710,597 | I: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP Director | 2022-06-29 | Grant or award · Non-Qualified Share Option (right to buy) | +60,000 | 60,000 | I: show line 3 in the form |
Loading xslF345X03/doc4.xml…